Table 1 Sociodemographic and clinical profiles of the samples studied (n = 224; 159 public psychiatry patients and 72 private psychiatry patients)
Global | Public | Private | P value | |
|---|---|---|---|---|
Women, n (%) | 139 (62.1) | 94 (61.8) | 45 (62.5) | .523a |
Mean age (SD) | 44,4 (15.1) | 41,2 (13.9) | 51,3 (15.1) | <.001b |
Education level, n (%) | ||||
Primary studies | 55 (24.6) | 37 (24.3) | 18 (25.0) | .004a |
Secondary studies | 103 (46.0) | 80 (52.6) | 23 (31.9) | |
University degree | 66 (29.5) | 35 (23.0) | 31 (43.1) | |
Time as psychiatric patient (moths), mean (SD) | 77,9 (106) | 73.3 (104) | 89.8 (110) | .340b |
Number of psychiatric drugs used, mean (SD) | 1.7 (1.3) | 1.88(1.4) | 1.85(.9) | .855b |
Diagnosis, n (%) | ||||
Schizophrenia | 24 (11.9) | 18 (14.0) | 6 (8.3) | .546a |
Bipolar disorder | 10 (5.0) | 6 (4.7) | 4 (5.6) | |
Depressive disorder | 80 (39.8) | 53 (41.1) | 27 (37.5) | |
Anxiety disorder | 78 (39.3) | 46 (35.7) | 33 (45.8) | |
Personality disorder | 8 (4.0) | 6 (4.7) | 2 (2.8) | |
Preferences of Involvement in SDM, according CPS, n (%) | ||||
Active | 20 (9.1) | 18 (12.1) | 2 (2.9) | <.001a |
Active-Active | 5 (2.3) | 4 (2.7) | 1 (1.4) | |
Active-Collaborative | 15 (6.8) | 14 (9.4) | 1 (1.4) | |
Collaborative | 107 (48.9) | 81 (54.4) | 26 (37.1) | |
Collaborative-Active | 21 (9.6) | 13 (8.7) | 8 (11.4) | |
Collaborative-Passive | 86 (39.3) | 68 (45.6) | 18 (25.7) | |
Passive | 92 (42.0) | 50 (33.6) | 42 (60.0) | |
Passive-Collaborative | 64 (29.2) | 38 (25.5) | 26 (37.1) | |
Passive-Passive | 28 (12.8) | 12 (8.1) | 16 (22.9) | |
Health Beliefs Questionnaire Dimensions, mean (SD) | ||||
Internal health locus of control | 13.0 (4.0) | 12.7 (4.0) | 13.6 (3.9) | .119b |
Doctors health locus of control | 14.6 (3.7) | 14.1 (3.8) | 15.6 (3.1) | .003b |
Psychological reactance | 10.3 (3.7) | 10.5 (3.8) | 9.9 (3.6) | .280b |
Positive aspects of medications | 20.2 (6.3) | 19.0 (6.2) | 22.8 (5.7) | <.001b |
Negative aspects of medications | 9.5 (4.3) | 9.4 (4.4) | 9.6 (4.2) | .642b |